SMILE causes less inflammation and apoptosis

Article

Small incision lenticule extraction (SMILE) caused less keratocyte apoptosis, proliferation and inflammation compared with femtosecond laser LASIK, according to data from a recent animal model study.

Small incision lenticule extraction (SMILE) caused less keratocyte apoptosis, proliferation and inflammation compared with femtosecond laser LASIK, according to data from a recent animal model study.

Researchers at Fudan University, Shanghai, and Bronx Lebanon Hospital Center, Bronx, New York, USA, compared corneal wound healing and inflammation in 36 eyes of 35 rabbits undergoing SMILE to another 36 eyes of 36 rabbits undergoing femtosecond laser LASIK. All eyes were treated to a refractive correction of –6.00 DS/–1.00 DC. These eyes were then compared to 12 eyes that underwent no surgery as controls.

Corneal tissues were evaluated postoperatively at hour 4 and 24 with terminal deoxyribonucleotidyl transferase-mediated dUTP-digoxigenin nick-end labelling assay to detect apoptosis. At postoperative day 3, week 1 and month 1, they underwent immunocytochemistry for Ki67 to detect keratocyte proliferation, at postoperative day 1, day 3 and week 1, with immunocytochemistry for CD11b to detect inflammation.

Researchers found no adverse events after either procedure and postoperative corneal healing was uneventful in all cases. In eyes that underwent the SMILE procedure, there were significantly less TUNEL-positive corneal stromal cells at 4 hours and 24 hours postoperatively compared with the LASIK procedure (P ≤ 0.01). In addition, there were significantly less Ki67-positive cells in the SMILE group compared with the femtosecond laser LASIK group at day 3 and week 1 postoperatively (P

"In our study, CD11b-positive monocyte mediated inflammation was significantly less severe in postoperative week 1 in the SMILE group compared with the femtosecond LASIK group. We hypothesize that this could be due to the following reasons: a small incision for the lenticule extraction will produce fewer chemokines to attract inflammatory cells in the injury; the intrastromal dissection by a femtosecond laser contributes to reduced tissue injury compared with the stroma ablation by an excimer laser; there was less necrotic debris in the interface after refractive lenticule extraction (ReLEx)," concluded lead author Dr Zixian Dong, PhD, of the Institute of Ophthalmology, Eye and ENT Hospital, Fudan University, Shanghai, and fellow researchers.

To access the abstract and full text of the study, visit the British Journal of Ophthalmology.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.